Abell Bridget, Glasziou Paul, Hoffmann Tammy
Centre for Research in Evidence-Based Practice, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, 4229, Australia.
Sports Med Open. 2017 Dec;3(1):19. doi: 10.1186/s40798-017-0086-z. Epub 2017 May 5.
While the clinical benefits of exercise-based cardiac rehabilitation are well established, there is extensive variation in the interventions used within these trials. It is unknown whether variations in individual components of these exercise interventions provide different relative contributions to overall clinical outcomes. This study aims to systematically examine the relationship between individual components of the exercise intervention in cardiac rehabilitation (such as intensity and frequency) and clinical outcomes for people with coronary heart disease.
In this systematic review, eligible trials were identified via searches of databases (PubMed, Allied and Complementary Medicine, EMBASE, PEDro, Science Citation Index Expanded, CINAHL, The Cochrane Library, SPORTDiscus) from citation tracking and hand-searching. Studies were included if they were randomised trials of a structured exercise intervention (versus usual care) for participants with coronary heart disease and reported at least one of cardiovascular mortality, total mortality, myocardial infarction or revascularisation outcomes. Each included trial was assessed using the Cochrane Risk of Bias Tool. Authors were also contacted for missing intervention details or data. Random effects meta-analysis was performed to calculate a summary risk ratio (RR) with 95% confidence interval (CI) for the effect of exercise on outcomes. Random effects meta-regression and subgroup analyses were conducted to examine the association between pre-specified co-variates (exercise components or trial characteristics) and each clinical outcome.
Sixty-nine trials were included, evaluating 72 interventions which differed markedly in terms of exercise components. Exercise-based cardiac rehabilitation was effective in reducing cardiovascular mortality (RR 0.74, 95% CI 0.65 to 0.86), total mortality (RR 0.90, 95% CI 0.83 to 0.99) and myocardial infarction (RR 0.80, 95% CI 0.70 to 0.92). This effect generally demonstrated no significant differences across subgroups of patients who received various types of usual care, more or less than 150 min of exercise per week and of differing cardiac aetiologies. There was however some heterogeneity observed in the efficacy of cardiac rehabilitation in reducing total mortality based on the presence of lipid lowering therapy (I = 48%, p = 0.15 for subgroup treatment interaction effect). No single exercise component was identified through meta-regression as a significant predictor of mortality outcomes, although reductions in both total (RR 0.81, p = 0.042) and cardiovascular mortality (RR 0.72, p = 0.045) were observed in trials which reported high levels of participant exercise adherence, versus those which reported lower levels. A dose-response relationship was found between an increasing exercise session time and increasing risk of myocardial infarction (RR 1.01, p = 0.011) and the highest intensity of exercise prescribed and an increasing risk of percutaneous coronary intervention (RR 1.05, p = 0.047).
Exercise-based cardiac rehabilitation is effective at reducing important clinical outcomes in patients with coronary heart disease. While our analysis was constrained by the quality of included trials and missing information about intervention components, there appears to be little differential effect of variations in exercise intervention, particularly on mortality outcomes. Given the observed effect between higher adherence and improved outcomes, it may be more important to provide exercise-based cardiac rehabilitation programs which focus on achieving increased adherence to the exercise intervention.
虽然基于运动的心脏康复的临床益处已得到充分证实,但这些试验中所采用的干预措施存在广泛差异。尚不清楚这些运动干预的各个组成部分的差异是否会对总体临床结局产生不同的相对影响。本研究旨在系统地探讨心脏康复运动干预的各个组成部分(如强度和频率)与冠心病患者临床结局之间的关系。
在本系统评价中,通过检索数据库(PubMed、联合与补充医学数据库、EMBASE、PEDro、科学引文索引扩展版、CINAHL、Cochrane图书馆、SPORTDiscus)、引文追踪和手工检索来确定符合条件的试验。纳入的研究需为针对冠心病患者的结构化运动干预(对比常规护理)的随机试验,并报告心血管死亡率、总死亡率、心肌梗死或血运重建结局中的至少一项。每项纳入试验均使用Cochrane偏倚风险工具进行评估。还会联系作者以获取缺失的干预细节或数据。进行随机效应荟萃分析以计算运动对结局影响的汇总风险比(RR)及95%置信区间(CI)。进行随机效应荟萃回归和亚组分析以检验预先设定的协变量(运动组成部分或试验特征)与每个临床结局之间的关联。
纳入69项试验,评估了72种在运动组成部分上有显著差异的干预措施。基于运动的心脏康复在降低心血管死亡率(RR 0.74,95% CI 0.65至0.86)、总死亡率(RR 0.90,95% CI 0.83至0.99)和心肌梗死(RR 0.80,95% CI 0.70至0.92)方面有效。在接受各种类型常规护理、每周运动或多或少超过150分钟以及不同心脏病因的患者亚组中,这种效果总体上无显著差异。然而,基于降脂治疗的存在,在心脏康复降低总死亡率的疗效方面观察到一些异质性(亚组治疗交互效应的I² = 48%,p = 0.15)。通过荟萃回归未发现单一运动组成部分是死亡率结局的显著预测因素,不过与报告较低参与者运动依从性的试验相比,在报告高运动依从性的试验中观察到总死亡率(RR 0.81,p = 0.042)和心血管死亡率(RR 0.72,p = 0.045)均有所降低。发现运动时长增加与心肌梗死风险增加(RR 1.01,p = 0.011)以及规定的最高运动强度与经皮冠状动脉介入治疗风险增加(RR 1.05,p = 0.047)之间存在剂量反应关系。
基于运动的心脏康复在降低冠心病患者的重要临床结局方面有效。虽然我们的分析受到纳入试验的质量以及干预组成部分信息缺失的限制,但运动干预的差异似乎几乎没有不同影响,尤其是对死亡率结局。鉴于观察到较高依从性与改善结局之间的关系,提供注重提高运动干预依从性的基于运动的心脏康复项目可能更为重要。